Safety of fibrates in cholestatic liver diseases.

Andres F Carrion Keith D Lindor Cynthia Levy

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

Fibrates appear to be safe and well tolerated in patients with PBC, with a low frequency of AEs. There are scarce data about the safety of these agents for treatment of PSC.

Keyphrases

electronic health record
liver injury
big data
liver fibrosis
combination therapy
artificial intelligence